The University of Queensland

Development and validation of nerve-targeted bacteriochlorin sensors

Hernández-Gil, Javier, Chow, Chun Yuen, Chatras, Hugo, de Souza França, Paula Demétrio, Samuels, Zachary V., Cornejo, Mike, King, Glenn F., Lewis, Jason S., Reiner, Thomas and Gonzales, Junior (2023). Development and validation of nerve-targeted bacteriochlorin sensors. Journal of the American Chemical Society, 145 (26), 14276-14287. doi: 10.1021/jacs.3c02520

The voltage‐gated sodium channel NaV 1 .7 underlies endometriosis‐associated chronic pelvic pain

Castro, Joel, Maddern, Jessica, Chow, Chun Yuen, Tran, Poanna, Vetter, Irina, King, Glenn F. and Brierley, Stuart M. (2023). The voltage‐gated sodium channel NaV 1 .7 underlies endometriosis‐associated chronic pelvic pain. Journal of Neurochemistry. doi: 10.1111/jnc.15795

Cysteine-rich α-conotoxin SII displays novel interactions at the muscle nicotinic acetylcholine receptor

Wilhelm, Patrick, Luna-Ramirez, Karen, Chin, Yanni K.-Y., Dekan, Zoltan, Abraham, Nikita, Tae, Han-Shen, Chow, Chun Yuen, Eagles, David A., King, Glenn F., Lewis, Richard J., Adams, David J. and Alewood, Paul F. (2022). Cysteine-rich α-conotoxin SII displays novel interactions at the muscle nicotinic acetylcholine receptor. ACS Chemical Neuroscience, 13 (8), 1245-1250. doi: 10.1021/acschemneuro.1c00857

Therapeutic inhibition of acid sensing ion channel 1a recovers heart function after ischemia-reperfusion injury

Redd, Meredith A., Scheuer, Sarah E., Saez, Natalie J., Yoshikawa, Yusuke, Chiu, Han Sheng, Gao, Ling, Hicks, Mark, Villanueva, Jeanette E., Joshi, Yashutosh, Chow, Chun Yuen, Cuellar-Partida, Gabriel, Peart, Jason N., See Hoe, Louise E., Chen, Xiaoli, Sun, Yuliangzi, Suen, Jacky Y., Hatch, Robert J., Rollo, Ben, Xiao, Di, Alzubaidi, Mubarak A.H., Maljevic, Snezana, Quaife-Ryan, Gregory A., Hudson, James E., Porrello, Enzo R., White, Melanie Y., Cordwell, Stuart J., Fraser, John F., Petrou, Steven, Reichelt, Melissa E. ... Palpant, Nathan J. (2021). Therapeutic inhibition of acid sensing ion channel 1a recovers heart function after ischemia-reperfusion injury. Circulation, 144 (12), 947-960. doi: 10.1161/circulationaha.121.054360

Pharmacological Inhibition of the Voltage-Gated Sodium Channel Nav1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome

Jiang, Yan, Castro, Joel, Blomster, Linda V., Agwa, Akello J., Maddern, Jessica, Schober, Gudrun, Herzig, Volker, Chow, Chun Yuen, Cardoso, Fernanda C., Demétrio De Souza França, Paula, Gonzales, Junior, Schroeder, Christina I., Esche, Steffen, Reiner, Thomas, Brierley, Stuart M. and King, Glenn F. (2021). Pharmacological Inhibition of the Voltage-Gated Sodium Channel Nav1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome. ACS Pharmacology & Translational Science, 4 (4) acsptsci.1c00072, 1362-1378. doi: 10.1021/acsptsci.1c00072

Fifteen years of NaV1.7 channels as an analgesic target: Why has excellent in vitro pharmacology not translated into in vivo analgesic efficacy?

Eagles, David A., Chow, Chun Yuen and King, Glenn F. (2020). Fifteen years of NaV1.7 channels as an analgesic target: Why has excellent in vitro pharmacology not translated into in vivo analgesic efficacy?. British Journal of Pharmacology, 179 (14) bph.15327, 3592-3611. doi: 10.1111/bph.15327

Venom-derived modulators of epilepsy-related ion channels

Chow, Chun Yuen, Absalom, Nathan, Biggs, Kimberley, King, Glenn F. and Ma, Linlin (2020). Venom-derived modulators of epilepsy-related ion channels. Biochemical Pharmacology, 181 114043, 114043. doi: 10.1016/j.bcp.2020.114043

A selective naV1.1 activator with potential for treatment of dravet syndrome epilepsy

Chow, Chun Yuen, Chin, Yanni K.Y., Ma, Linlin, Undheim, Eivind A.B., Herzig, Volker and King, Glenn F. (2020). A selective naV1.1 activator with potential for treatment of dravet syndrome epilepsy. Biochemical Pharmacology, 181 113991, 113991. doi: 10.1016/j.bcp.2020.113991

Fluorescence labeling of a NaV1.7-targeted peptide for near-infrared nerve visualization

Gonzales, Junior, Pirovano, Giacomo, Chow, Chun Yuen, de Souza Franca, Paula Demetrio, Carter, Lukas M., Klint, Julie K., Guru, Navjot, Lewis, Jason S., King, Glenn F. and Reiner, Thomas (2020). Fluorescence labeling of a NaV1.7-targeted peptide for near-infrared nerve visualization. EJNMMI Research, 10 (1) 49, 49. doi: 10.1186/s13550-020-00630-4

Venom peptides with dual modulatory activity on the voltage-gated sodium channel NaV1.1 provide novel leads for development of antiepileptic drugs

Chow, Chun Yuen, Chin, Yanni K.-Y., Walker, Andrew A., Guo, Shaodong, Blomster, Linda V., Ward, Micaiah J., Herzig, Volker, Rokyta, Darin R. and King, Glenn F. (2019). Venom peptides with dual modulatory activity on the voltage-gated sodium channel NaV1.1 provide novel leads for development of antiepileptic drugs. ACS Pharmacology & Translational Science, 3 (1) acsptsci.9b00079, 119-134. doi: 10.1021/acsptsci.9b00079

Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target

Ma, Linlin, Chin, Yanni K.Y., Dekan, Zoltan, Herzig, Volker, Chow, Chun Yuen, Heighway, Jacqueline, Lam, Sau Wing, Guillemin, Gilles J., Alewood, Paul F. and King, Glenn F. (2018). Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target. Biochemical Pharmacology, 158, 60-72. doi: 10.1016/j.bcp.2018.08.038

Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death

Richards, Kay L., Milligan, Carol J., Richardson, Robert J., Jancovski, Nikola, Grunnet, Morten, Jacobson, Laura H., Undheim, Eivind A. B., Mobli, Mehdi, Chow, Chun Yuen, Herzig, Volker, Csoti, Agota, Panyi, Gyorgy, Reid, Christopher A., King, Glenn F. and Petrou, Steven (2018). Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death. Proceedings of the National Academy of Sciences, 115 (34), 201804764-E8085. doi: 10.1073/pnas.1804764115

Gating modifier toxins isolated from spider venom: modulation of voltage-gated sodium channels and the role of lipid membranes

Agwa, Akello J., Peigneur, Steve, Chow, Chun Yuen, Lawrence, Nicole, Craik, David J., Tytgat, Jan, King, Glenn F., Henriques, Sonia Troeira and Schroeder, Christina I. (2018). Gating modifier toxins isolated from spider venom: modulation of voltage-gated sodium channels and the role of lipid membranes. Journal of Biological Chemistry, 293 (23), 9041-9052. doi: 10.1074/jbc.RA118.002553

Three peptide modulators of the human voltage-gated sodium channel 1.7, an important analgesic target, from venom of an Australian tarantula

Chow, Chun Yuen, Cristofori-Armstrong, Ben, Undheim, Eivind A. B., King, Glenn F. and Rash, Lachlan D. (2015). Three peptide modulators of the human voltage-gated sodium channel 1.7, an important analgesic target, from venom of an Australian tarantula. Toxins, 7 (7), 2494-2513. doi: 10.3390/toxins7072494

The use of peptide-membrane interactions in the design of selective and potent sodium channel inhibitors

Schroeder, Christina, Agwa, Akello, Mueller, Alexander, Chow, Chun Yuen, Peigneur, Steve, Lawrence, Nicole, Deplazes, Evelyne, Mark, Alan, Craik, David, Tytgat, Jan, King, Glenn, Vetter, Irina and Henriques, Sonia Troeira (2018). The use of peptide-membrane interactions in the design of selective and potent sodium channel inhibitors. 35th European Peptide Symposium, Dublin City University, Ireland, 26-31 August 2018. Oxford, United Kingdom: John Wiley & Sons.

Novel Human Eag Channel Antagonists from Spider Venoms

Ma, Linlin, Chin, Yanni K., Dekan, Zoltan, Ikonomopoulou, Maria, Herzig, Volker, Chow, Chun Yuen, Alewood, Paul and King, Glenn F. (2017). Novel Human Eag Channel Antagonists from Spider Venoms. 58th Annual Meeting of the Biophysical-Society, San Francisco, CA, United States, 15-19 February 2014. St. Louis, MO 63146 United States: Cell Press. doi: 10.1016/j.bpj.2016.11.1800

Development of NaV1.1-selective agonists with potential for treatment of Dravet syndrome epilepsy

Chow, Chun Yuen (2019). Development of NaV1.1-selective agonists with potential for treatment of Dravet syndrome epilepsy. PhD Thesis, Institute for Molecular Bioscience, The University of Queensland. doi: 10.14264/uql.2019.883